Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse Model

In a xenograft model wherein, live renal cancer cells were implanted under the kidney capsule in mice, revealed a 30-fold increase in tumor volume over a period of 26 days and this was accompanied with a 32-fold increase in the level of lactosylceramide (LacCer). Mice fed D- threo-1-phenyl-2-decanoy...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Subroto, Alsaeedi, Nezar, Hou, Jennifer, Bandaru, Veera Venkata Ratnam, Wu, Lan, Halushka, Marc K., Pili, Roberto, Ndikuyeze, Georges, Haughey, Norman J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650082/
https://www.ncbi.nlm.nih.gov/pubmed/23671696
http://dx.doi.org/10.1371/journal.pone.0063726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650082/
https://www.ncbi.nlm.nih.gov/pubmed/23671696
http://dx.doi.org/10.1371/journal.pone.0063726

Ejemplares similares